EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular nociceptive mechanisms in migraine: The migraine cascade

Song Guo iD, Sarah Louise Christensen, Mohammad Al-Mahdi Al-Karagholi, Jes Olesen iD

European Journal of Neurology · 2024-08 · 31 (8)

DOI: 10.1111/ene.16333 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Neurology, online erschienen am 18.06.2024. Verfasst von Song Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, Univ…. Hauptthemen laut MEDLINE: Migraine Disorders, Pituitary Adenylate Cyclase-Activating Polypeptide, Nociception. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This review will explore the categorization of migraine‐provoking molecules, their cellular actions, site of action and potential drug targets based on the migraine cascade model.

Methods

Personal experience and literature.

Results

Migraine impacts over 1 billion people worldwide but is underfunded in research. Recent progress, particularly through the human and animal provocation model, has deepened our understanding of its mechanisms. This model have identified endogenous neuropeptides such as calcitonin gene‐related peptide (CGRP) and pituitary adenylate cyclase‐activating peptide (PACAP) that induces controlled migraine‐like attacks leading to significant discoveries of their role in migraine. This knowledge led to the development of CGRP‐inhibiting drugs; a groundbreaking migraine treatment now accessible globally. Also a PACAP‐inhibiting drug was effective in a recent phase II trial. Notably, rodent studies have shed light on pain pathways and the mechanisms of various migraine‐inducing substances identifying novel drug targets. This is primarily done by using selective inhibitors that target specific signaling pathways of the known migraine triggers leading to the hypothesized cellular cascade model of migraine.

Conclusion

The model of migraine presents numerous opportunities for innovative drug development. The future of new migraine treatments is limited only by the investment from pharmaceutical companies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersPituitary Adenylate Cyclase-Activating PolypeptideNociceptionHumansAnimalsCalcitonin Gene-Related Peptide

Stichwörter der Autor:innen

CGRPPACAPanimal modelexperimental headachehuman provocation modelmigrainemigraine trigger

Substanzen

Pituitary Adenylate Cyclase-Activating PolypeptideCalcitonin Gene-Related Peptide

Autor:innen und Institutionen

  • Danish Headache Center, Department of Neurology, Translational Research Center, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
  • Department of Neurology, Zealand University Hospital, Roskilde, Denmark.

ORCID-Profile: Song Guo, Jes Olesen

Zitieren

APA

Guo, S., Christensen, S. L., Al-Karagholi, M. A., & Olesen, J. (2024). Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16333

Vancouver

Guo S, Christensen SL, Al-Karagholi MA, Olesen J. Molecular nociceptive mechanisms in migraine: The migraine cascade. European Journal of Neurology. 2024;31(8). doi:10.1111/ene.16333

BibTeX
@article{Guo2024,
  author = {Guo, Song and Christensen, Sarah Louise and Al-Karagholi, Mohammad Al-Mahdi and Olesen, Jes},
  title = {Molecular nociceptive mechanisms in migraine: The migraine cascade},
  journal = {European Journal of Neurology},
  year = {2024},
  volume = {31},
  number = {8},
  doi = {10.1111/ene.16333}
}
Kostenlos starten →